Literature DB >> 18616660

Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery.

Venkataraman Subramanian1, Sonia Saxena, Jin-Yong Kang, Richard C G Pollok.   

Abstract

CONTEXT: Corticosteroids are the mainstay of medical therapies to induce remission in acute episodes of inflammatory bowel disease (IBD). However, evidence suggests that this may increase the risk of postoperative complications among patients with IBD who go on to have abdominal surgery.
OBJECTIVE: To estimate the risk of postoperative complications following abdominal surgery in patients with IBD on steroids at the time of abdominal surgery.
DESIGN: Meta-analysis of observational studies.
METHODS: We searched medical electronic databases for full journal articles published after 1965 reporting on postoperative complications in patients with IBD undergoing abdominal surgery provided they compared patients treated with steroids with those not on steroids. We hand searched the reference lists of all retrieved articles. Two independent reviewers extracted data from studies meeting the inclusion criteria and any discrepancies were resolved by discussion. We carried out fixed effects meta-analysis, funnel plot and sensitivity analyses.
RESULTS: A total of seven observational studies involving 1,532 patients met the inclusion criteria for risk of total complications, and five observational studies involving 1,714 patients met the inclusion criteria for risk of infectious complications. Pooled analysis showed an increased risk of all postoperative complications (OR 1.41, 95% confidence interval 1.07-1.87), as well as an increased risk of postoperative infectious complications (OR 1.68, 95% confidence interval 1.24-2.28) among patients on steroids. Patients who received higher doses of perioperative oral steroids (>40 mg) had a higher risk of total complications (OR 2.04 (95% CI 1.28-3.26).
CONCLUSIONS: There is an increased risk of total as well as infectious complications following the use of steroids in patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18616660     DOI: 10.1111/j.1572-0241.2008.01942.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  45 in total

1.  Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.

Authors:  Basil S Nasir; Eric J Dozois; Robert R Cima; John H Pemberton; Bruce G Wolff; William J Sandborn; Edward V Loftus; David W Larson
Journal:  J Gastrointest Surg       Date:  2010-09-25       Impact factor: 3.452

2.  The effect of pre-operative optimization on post-operative outcome in Crohn's disease resections.

Authors:  Alaa El-Hussuna; Igors Iesalnieks; Nir Horesh; Sabah Hadi; Yael Dreznik; Oded Zmora
Journal:  Int J Colorectal Dis       Date:  2016-10-26       Impact factor: 2.571

3.  Using corticosteroids appropriately in inflammatory bowel disease: a guide for primary care.

Authors:  Kevin Barrett; Sonia Saxena; Richard Pollok
Journal:  Br J Gen Pract       Date:  2018-10       Impact factor: 5.386

Review 4.  Perioperative Considerations in Crohn Disease and Ulcerative Colitis.

Authors:  T Paul Nickerson; Amit Merchea
Journal:  Clin Colon Rectal Surg       Date:  2016-06

5.  Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.

Authors:  Chaya Shwaartz; Adam C Fields; Maximiliano Sobrero; Brian D Cohen; Celia M Divino
Journal:  J Gastrointest Surg       Date:  2016-07-12       Impact factor: 3.452

Review 6.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

7.  Associations Between the Prognostic Nutritional Index and Morbidity/Mortality During Intestinal Resection in Patients with Ulcerative Colitis.

Authors:  Teruhiro Chohno; Motoi Uchino; Hirofumi Sasaki; Toshihiro Bando; Yoshio Takesue; Hiroki Ikeuchi
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

8.  Inflammatory Bowel Disease Is Not a Contraindication for Bariatric Surgery.

Authors:  Stephanie Aelfers; Ignace M C Janssen; Edo O Aarts; Carolijn Smids; Marcel J Groenen; Frits J Berends
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

Review 9.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.

Authors:  G Pellino; D S Keller; G M Sampietro; M Carvello; V Celentano; C Coco; F Colombo; A Geccherle; G Luglio; M Rottoli; M Scarpa; G Sciaudone; G Sica; L Sofo; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-02       Impact factor: 3.781

Review 10.  Preoperative optimization of crohn disease.

Authors:  Amit Sharma; Bertram T Chinn
Journal:  Clin Colon Rectal Surg       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.